EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease

Hilla Chen iD, Gilad Segev iD, Michal Mazaki-Tovi iD

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.70063 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2025. Written by Hilla Chen and 2 co-authors. Institution: Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel. Major MEDLINE topics: Ergocalciferols, Proteinuria, Dog Diseases, Hyperparathyroidism, Secondary. 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: European College of Veterinary Internal Medicine - Companion Animals (ECVIM-CA) Clinical Studies Fund Purina Institute Resident Research Award.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Renal secondary hyperparathyroidism (RHPT) is an inevitable consequence of chronic kidney disease (CKD). Paricalcitol might safely attenuate RHPT and proteinuria. Hypothesis/Objective Paricalcitol decreases parathyroid hormone (PTH) and proteinuria in dogs with CKD. Animals Thirteen dogs with naturally acquired CKD.

Methods

Placebo-controlled clinical trial. Dogs were randomly allocated to receive a placebo or paricalcitol (14 ng/kg/day) in a crossover design of 2, 12-week arms. Dogs were evaluated every 3 weeks. Associations between treatment, visit, and the outcome variables were assessed using generalized estimating equations.

Results

PTH decreased by 22% (95% CI, 7%–35%, p = 0.006) in the paricalcitol-treated dogs and increased by 18% (95% CI, 2%–37%, p = 0.022) in the placebo-treated dogs with each visit. FGF-23 at 12 weeks increased compared with baseline in the paricalcitol-treated (mean 6941 pg/mL, 95% CI, 1781–20 057 vs. 489 pg/mL, 95% CI, 188–1272, p < 0.001, respectively), but not in the placebo-treated dogs (696 pg/mL, 95% CI, 316–1531 vs. 955 pg/mL, 95% CI, 308–2963, p = 0.529). Urine protein-to-creatinine ratio at 12 weeks increased compared with baseline in the placebo-treated (0.8, 95% CI, 0.3–1.3 vs. 0.5, 95% CI, 0.2–0.9, p = 0.04, respectively), but not in the paricalcitol-treated dogs (0.6, 95% CI, 0.3–0.9 vs. 1.0, 95% CI, 0.1–1.8, p = 0.35). Ionized calcium was unchanged between baseline and 12 weeks in the paricalcitol- and placebo-treated groups (1.3 mmol/L, 95% CI, 1.29–1.35 and 1.34, 95% CI, 1.27–1.40 vs. 1.30, 95% CI, 1.25–1.35, p = 0.12 and 1.28, 95% CI, 1.24–1.32, p = 0.034, respectively). However, 7/13 dogs developed mild hypercalcemia. Adverse effects were not reported by the owners. Conclusion and Clinical Importance Paricalcitol attenuated RHPT and stabilized renal proteinuria in dogs with CKD.

Subjects

MeSH terms (MEDLINE)

ErgocalciferolsProteinuriaDog DiseasesHyperparathyroidism, SecondaryRenal Insufficiency, ChronicAnimalsDogsFemaleMaleCross-Over StudiesParathyroid HormoneFibroblast Growth Factor-23Fibroblast Growth Factors

Author keywords

FGF‐23mineral bone disorderparathyroid hormonevitamin D

Substances

paricalcitolErgocalciferolsParathyroid HormoneFibroblast Growth Factor-23Fibroblast Growth Factors

Authors and institutions

  • Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel.

ORCID profiles: Hilla Chen, Gilad Segev, Michal Mazaki-Tovi

Funding

  • European College of Veterinary Internal Medicine - Companion Animals (ECVIM-CA) Clinical Studies Fund Purina Institute Resident Research Award

Cite

APA

Chen, H., Segev, G., & Mazaki-Tovi, M. (2025). Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70063

Vancouver

Chen H, Segev G, Mazaki-Tovi M. Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70063

BibTeX
@article{Chen2025,
  author = {Chen, Hilla and Segev, Gilad and Mazaki-Tovi, Michal},
  title = {Effects of Paricalcitol on Renal Secondary Hyperparathyroidism and Proteinuria in Dogs With Chronic Kidney Disease},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.70063}
}
Start for free →